XML 28 R19.htm IDEA: XBRL DOCUMENT v3.21.2
EQUITY INVESTMENT AND ROYALTIES - Schedule of Stock Options, Valuation Assumptions (Details) - Cell MedX Corp. [Member]
6 Months Ended
Jun. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Risk-free rate (%) 0.25%
Expected stock price volatility (%) 132.03%
Expected dividend yield (%) 0.00%
Expected life of options (years) 1 year 6 months 29 days